Amend paragraph (1)(A)(iii) of Section 1106(b) to replace the phrase "prevention and treatment of sickle cell disease" with "treatment of sickle cell disease and the prevention and treatment of complications of sickle cell disease."

Amend paragraph (2)(D) of Section 1106(b) to replace the phrase "prevention and treatment of sickle cell disease" with "treatment of sickle cell disease and the prevention and treatment of complications of sickle cell disease."

Amend paragraph (3) of Section 1106(b): (A) in subparagraph (A), change the authority from "enter into a contract with" to "make a grant to, or enter into a contract or cooperative agreement with,"; (B) in subparagraph (B), in clauses (ii) and (iii), replace "prevention and treatment of sickle cell disease" with "treatment of sickle cell disease and the prevention and treatment of complications of sickle cell disease."

Amend paragraph (6) of Section 1106(b) by striking the funding level "$4,455,000 for each of fiscal years 2019 through 2023" and inserting "$8,205,000 for each of fiscal years 2025 through 2029."

Sense of Congress: further research should be undertaken to expand understanding of the causes of, and to find cures for, heritable blood disorders, including sickle cell disease.